Although this study did not model the Tcf7l2 SNP associated with the risk of type 2 diabetes, based on its potential to utilise the excess glucose pool more efficiently, we suggest that TCF7L2 may be a promising regulator of NAFLD associated with dietary carbohydrates and diabetes. Here, TCF7L2 is linked to metabolic dysfunction-associated steatotic liver disease.